Nepafenac Once Daily for Macular Edema - Study 2

Clinical trial NCT01872611 · COMPLETED

Trial details

NCT number: NCT01872611
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Proliferative Diabetic Retinopathy Cataract

Start date: 2013-06-01
Primary completion: 2015-05-01
Enrollment: 819

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.